217 related articles for article (PubMed ID: 35397210)
21. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).
Allemani C; Weir HK; Carreira H; Harewood R; Spika D; Wang XS; Bannon F; Ahn JV; Johnson CJ; Bonaventure A; Marcos-Gragera R; Stiller C; Azevedo e Silva G; Chen WQ; Ogunbiyi OJ; Rachet B; Soeberg MJ; You H; Matsuda T; Bielska-Lasota M; Storm H; Tucker TC; Coleman MP;
Lancet; 2015 Mar; 385(9972):977-1010. PubMed ID: 25467588
[TBL] [Abstract][Full Text] [Related]
22. Comparison of liver cancer incidence and survival by subtypes across seven high-income countries.
Rutherford MJ; Arnold M; Bardot A; Ferlay J; De P; Tervonen H; Little A; Bucher O; St Jacques N; Gavin A; Engholm G; Møller B; O'Connell DL; Merrett N; Parkin DM; Bray F; Soerjomataram I
Int J Cancer; 2021 Dec; 149(12):2020-2031. PubMed ID: 34460109
[TBL] [Abstract][Full Text] [Related]
23. International variation in oesophageal and gastric cancer survival 2012-2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study).
Arnold M; Morgan E; Bardot A; Rutherford MJ; Ferlay J; Little A; Møller B; Bucher O; De P; Woods RR; Saint-Jacques N; Gavin AT; Engholm G; Achiam MP; Porter G; Walsh PM; Vernon S; Kozie S; Ramanakumar AV; Lynch C; Harrison S; Merrett N; O'Connell DL; Mala T; Elwood M; Zalcberg J; Huws DW; Ransom D; Bray F; Soerjomataram I
Gut; 2022 Aug; 71(8):1532-1543. PubMed ID: 34824149
[TBL] [Abstract][Full Text] [Related]
24. Emergency department presentations with a mental health diagnosis in Australia, by jurisdiction and by sex, 2004-05 to 2016-17.
Tran QN; Lambeth LG; Sanderson K; de Graaff B; Breslin M; Tran V; Huckerby EJ; Neil AL
Emerg Med Australas; 2020 Jun; 32(3):383-392. PubMed ID: 31854113
[TBL] [Abstract][Full Text] [Related]
25. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
[TBL] [Abstract][Full Text] [Related]
26. Investigation of the international comparability of population-based routine hospital data set derived comorbidity scores for patients with lung cancer.
Lüchtenborg M; Morris EJA; Tataru D; Coupland VH; Smith A; Milne RL; Te Marvelde L; Baker D; Young J; Turner D; Nishri D; Earle C; Shack L; Gavin A; Fitzpatrick D; Donnelly C; Lin Y; Møller B; Brewster DH; Deas A; Huws DW; White C; Warlow J; Rashbass J; Peake MD
Thorax; 2018 Apr; 73(4):339-349. PubMed ID: 29079609
[TBL] [Abstract][Full Text] [Related]
27. Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries.
Soerjomataram I; Cabasag C; Bardot A; Fidler-Benaoudia MM; Miranda-Filho A; Ferlay J; Parkin DM; Ranganathan R; Piñeros M; Znaor A; Mery L; Joko-Fru YW; Dikshit R; Sankaranarayanan R; Swaminathan R; Bray F;
Lancet Oncol; 2023 Jan; 24(1):22-32. PubMed ID: 36603919
[TBL] [Abstract][Full Text] [Related]
28. Cancer incidence in indigenous people in Australia, New Zealand, Canada, and the USA: a comparative population-based study.
Moore SP; Antoni S; Colquhoun A; Healy B; Ellison-Loschmann L; Potter JD; Garvey G; Bray F
Lancet Oncol; 2015 Nov; 16(15):1483-1492. PubMed ID: 26476758
[TBL] [Abstract][Full Text] [Related]
29. International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study.
Araghi M; Fidler-Benaoudia M; Arnold M; Rutherford M; Bardot A; Ferlay J; Bucher O; De P; Engholm G; Gavin A; Kozie S; Little A; Møller B; St Jacques N; Tervonen H; Walsh P; Woods R; O'Connell DL; Baldwin D; Elwood M; Siesling S; Bray F; Soerjomataram I; ; ; ; ;
Thorax; 2022 Apr; 77(4):378-390. PubMed ID: 34282033
[TBL] [Abstract][Full Text] [Related]
30. Relative contribution of trends in myocardial infarction event rates and case fatality to declines in mortality: an international comparative study of 1·95 million events in 80·4 million people in four countries.
Camacho X; Nedkoff L; Wright FL; Nghiem N; Buajitti E; Goldacre R; Rosella LC; Seminog O; Tan EJ; Hayes A; Hayen A; Wilson N; Blakely T; Clarke P
Lancet Public Health; 2022 Mar; 7(3):e229-e239. PubMed ID: 35247353
[TBL] [Abstract][Full Text] [Related]
31. Comparability of stage data in cancer registries in six countries: lessons from the International Cancer Benchmarking Partnership.
Walters S; Maringe C; Butler J; Brierley JD; Rachet B; Coleman MP
Int J Cancer; 2013 Feb; 132(3):676-85. PubMed ID: 22623157
[TBL] [Abstract][Full Text] [Related]
32. An International Consensus on Actions to Improve Lung Cancer Survival: A Modified Delphi Method Among Clinical Experts in the International Cancer Benchmarking Partnership.
Lynch C; Harrison S; Butler J; Baldwin DR; Dawkins P; van der Horst J; Jakobsen E; McAleese J; McWilliams A; Redmond K; Swaminath A; Finley CJ
Cancer Control; 2022; 29():10732748221119354. PubMed ID: 36269109
[TBL] [Abstract][Full Text] [Related]
33. Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000-2007.
Maringe C; Walters S; Rachet B; Butler J; Fields T; Finan P; Maxwell R; Nedrebø B; Påhlman L; Sjövall A; Spigelman A; Engholm G; Gavin A; Gjerstorff ML; Hatcher J; Johannesen TB; Morris E; McGahan CE; Tracey E; Turner D; Richards MA; Coleman MP;
Acta Oncol; 2013 Jun; 52(5):919-32. PubMed ID: 23581611
[TBL] [Abstract][Full Text] [Related]
34. A comparative analysis: international variation in PET-CT service provision in oncology-an International Cancer Benchmarking Partnership study.
Lynch C; Reguilon I; Langer DL; Lane D; De P; Wong WL; Mckiddie F; Ross A; Shack L; Win T; Marshall C; Revheim ME; Danckert B; Butler J; Dizdarevic S; Louzado C; Mcgivern C; Hazlett A; Chew C; O'connell M; Harrison S
Int J Qual Health Care; 2021 Feb; 33(1):. PubMed ID: 33306102
[TBL] [Abstract][Full Text] [Related]
35. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
36. Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study.
Tomic D; Morton JI; Chen L; Salim A; Gregg EW; Pavkov ME; Arffman M; Balicer R; Baviera M; Boersma-van Dam E; Brinks R; Carstensen B; Chan JCN; Cheng YJ; Fosse-Edorh S; Fuentes S; Gardiner H; Gulseth HL; Gurevicius R; Ha KH; Hoyer A; Jermendy G; Kautzky-Willer A; Keskimäki I; Kim DJ; Kiss Z; Klimek P; Leventer-Roberts M; Lin CY; Lopez-Doriga Ruiz P; Luk AOY; Ma S; Mata-Cases M; Mauricio D; McGurnaghan S; Imamura T; Paul SK; Peeters A; Pildava S; Porath A; Robitaille C; Roncaglioni MC; Sugiyama T; Wang KL; Wild SH; Yekutiel N; Shaw JE; Magliano DJ
Lancet Diabetes Endocrinol; 2022 Nov; 10(11):795-803. PubMed ID: 36183736
[TBL] [Abstract][Full Text] [Related]
37. International variation in childhood cancer mortality rates from 2001 to 2015: Comparison of trends in the International Cancer Benchmarking Partnership countries.
Smith L; Stiller CA; Aitken JF; Hjalgrim LL; Johannesen T; Lahteenmaki P; McCabe MG; Phillips R; Pritchard-Jones K; Steliarova-Foucher E; Winther JF; Woods RR; Glaser AW; Feltbower RG
Int J Cancer; 2022 Jan; 150(1):28-37. PubMed ID: 34449879
[TBL] [Abstract][Full Text] [Related]
38. 3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.
Iveson T; Boyd KA; Kerr RS; Robles-Zurita J; Saunders MP; Briggs AH; Cassidy J; Hollander NH; Tabernero J; Haydon A; Glimelius B; Harkin A; Allan K; McQueen J; Pearson S; Waterston A; Medley L; Wilson C; Ellis R; Essapen S; Dhadda AS; Harrison M; Falk S; Raouf S; Rees C; Olesen RK; Propper D; Bridgewater J; Azzabi A; Farrugia D; Webb A; Cunningham D; Hickish T; Weaver A; Gollins S; Wasan H; Paul J
Health Technol Assess; 2019 Dec; 23(64):1-88. PubMed ID: 31852579
[TBL] [Abstract][Full Text] [Related]
39. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
[TBL] [Abstract][Full Text] [Related]
40. Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking Partnership.
Maringe C; Walters S; Butler J; Coleman MP; Hacker N; Hanna L; Mosgaard BJ; Nordin A; Rosen B; Engholm G; Gjerstorff ML; Hatcher J; Johannesen TB; McGahan CE; Meechan D; Middleton R; Tracey E; Turner D; Richards MA; Rachet B;
Gynecol Oncol; 2012 Oct; 127(1):75-82. PubMed ID: 22750127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
